CPV design for transdermal, inhalation and other specialised dosage forms

CPV Design for Transdermal, Inhalation and Other Specialised Dosage Forms CPV Design for Transdermal, Inhalation and Other Specialised Dosage Forms Continued Process Verification (CPV) is a critical regulatory requirement outlined by the FDA and other global health authorities for the manufacturing of pharmaceutical products. This systematic approach ensures the quality and consistency of complex manufacturing processes and facilitates lifecycle performance management. The necessity of CPV becomes more pronounced in the context of specialised dosage forms such as transdermal and inhalation products, which present unique challenges in terms of formulation, manufacturing, and regulatory compliance. In this article, we explore the implementation…

Continue Reading... CPV design for transdermal, inhalation and other specialised dosage forms

How to handle long cycle times and infrequent batches in CPV for complex products

How to handle long cycle times and infrequent batches in CPV for complex products Handling Long Cycle Times and Infrequent Batches in CPV for Complex Products Continued Process Verification (CPV) is an essential aspect of modern pharmaceutical manufacturing and quality assurance, particularly in the context of complex products that involve intricate multistage processes. The FDA, along with European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA), emphasizes the importance of CPV in maintaining product quality, thereby ensuring patient safety. As pharmaceutical professionals face the challenges associated with long cycle times and infrequent batch production, it becomes crucial…

Continue Reading... How to handle long cycle times and infrequent batches in CPV for complex products

Hierarchical CPV monitoring from unit operation to end product CQA

Hierarchical CPV Monitoring from Unit Operation to End Product CQA Hierarchical CPV Monitoring from Unit Operation to End Product CQA Continued Process Verification (CPV) has emerged as a critical component in the lifecycle management of pharmaceutical products, especially in the context of complex manufacturing processes. As regulatory agencies such as the US FDA, EMA, and MHRA emphasize quality and compliance, the integration of robust CPV strategies becomes imperative. This article delineates the principles of hierarchical CPV monitoring, covering its implementation from unit operations through to the end product’s Critical Quality Attributes (CQA). Understanding Continued Process Verification (CPV) CPV is defined…

Continue Reading... Hierarchical CPV monitoring from unit operation to end product CQA

Common pitfalls under monitoring early or upstream stages in CPV

Common pitfalls under monitoring early or upstream stages in CPV Common Pitfalls Under Monitoring Early or Upstream Stages in CPV Continued Process Verification (CPV) has become an essential practice in the pharmaceutical industry, particularly for complex manufacturing operations. As pharmaceutical professionals traverse the regulatory landscape shaped by the US FDA, EMA, and MHRA, understanding the common pitfalls encountered while monitoring the early or upstream stages of CPV is crucial. Early engagement in CPV can be a differentiator between process reliability and regulatory repercussions. Understanding Continued Process Verification (CPV) Continued Process Verification (CPV) is defined by the FDA under the guidelines…

Continue Reading... Common pitfalls under monitoring early or upstream stages in CPV

Examples of best practice CPV for high complexity biologics and vaccines

Examples of Best Practice CPV for High Complexity Biologics and Vaccines Examples of Best Practice CPV for High Complexity Biologics and Vaccines In the biopharmaceutical industry, the intricacies involved in the manufacturing of biologics and vaccines present unique challenges, particularly when it comes to maintaining quality and compliance. Continued Process Verification (CPV) is a crucial component of quality assurance and process control, especially pertinent for complex manufacturing processes involving biologics. This article discusses best practices for CPV tailored for high complexity biologics and vaccines, reflecting both FDA and EMA regulatory frameworks to provide guidance for pharma professionals. Understanding Continued Process…

Continue Reading... Examples of best practice CPV for high complexity biologics and vaccines

Training cross functional teams on CPV approach for complex products

Training Cross Functional Teams on CPV Approach for Complex Products Training Cross Functional Teams on CPV Approach for Complex Products In the contemporary pharmaceutical landscape, the approach to Continued Process Verification (CPV) for complex products is evolving to align with regulatory expectations and technological advancements. Given the complexity of multistage manufacturing processes, cross-functional team training becomes pivotal for establishing a robust CPV strategy. This article aims to provide an in-depth regulatory explainer manual for pharma professionals involved in clinical operations, regulatory affairs, and medical affairs, focusing on FDA, EMA, and MHRA compliance. Understanding Continued Process Verification (CPV) Continued Process Verification…

Continue Reading... Training cross functional teams on CPV approach for complex products

Strategies for CPV when data is split across historian, MES and LIMS silos

Strategies for CPV when data is split across historian, MES and LIMS silos Strategies for CPV when data is split across historian, MES and LIMS silos Continued Process Verification (CPV) is an essential element of modern pharmaceutical manufacturing, particularly as industry practices become increasingly intricate. With the evolving complexities of biologics and sterile manufacturing processes, especially where multiple data repositories such as historians, Manufacturing Execution Systems (MES), and Laboratory Information Management Systems (LIMS) are involved, establishing a robust CPV strategy is crucial. In this article, we will explore CPV challenges and strategies, focusing on data integration across silos and the…

Continue Reading... Strategies for CPV when data is split across historian, MES and LIMS silos

CPV for tech transfer processes moving across sites and equipment

CPV for Tech Transfer Processes Moving Across Sites and Equipment Understanding CPV for Tech Transfer Processes Across Sites and Equipment Continued Process Verification (CPV) represents an essential approach in the realm of pharmaceutical manufacturing, especially as it pertains to complex and multistage manufacturing processes. The FDA, EMA, and MHRA are increasingly emphasizing CPV as a means to ensure product quality and process reliability during tech transfer across various sites and equipment. This regulatory explainer manual delves deeply into the intricacies of CPV, with a focused lens on technology transfer processes that encompass the nuanced requirements of biologics and sterile products…

Continue Reading... CPV for tech transfer processes moving across sites and equipment

Using nested and hierarchical control charts for multi stage CPV data

Using Nested and Hierarchical Control Charts for Multi Stage CPV Data Using Nested and Hierarchical Control Charts for Multi Stage CPV Data Continued Process Verification (CPV) is an essential component of modern pharmaceutical manufacturing processes, particularly in the context of complex and multistage manufacturing workflows. The adoption of data-driven methodologies is crucial in ensuring product quality and regulatory compliance. This article will explore the implementation of nested and hierarchical control charts in CPV specifically tailored for multi-stage processes, providing insights for regulatory affairs and quality assurance professionals. Understanding Continued Process Verification (CPV) in Complex Manufacturing Continued Process Verification, as defined…

Continue Reading... Using nested and hierarchical control charts for multi stage CPV data

Using LIMS data to enrich CPV monitoring of CQAs and specification trends

Using LIMS data to enrich CPV monitoring of CQAs and specification trends Using LIMS Data to Enhance CPV Monitoring of CQAs and Specification Trends In the realm of pharmaceutical manufacturing, Continued Process Verification (CPV) plays a pivotal role in ensuring product quality and compliance with regulatory standards. The process involves the ongoing assessment of manufacturing processes and the quality of the output to guarantee that it consistently meets predefined quality criteria. A key aspect of CPV is the integration of diverse data sources including Laboratory Information Management Systems (LIMS), Manufacturing Execution Systems (MES), and Quality Management Systems (QMS). This article…

Continue Reading... Using LIMS data to enrich CPV monitoring of CQAs and specification trends